Christopher R. Trevino
Expertise in
16
conditions

Dr. Christopher R. Trevino

Neurology | Hematology | Oncology
Endeavor Health Medical Group
1000 Central St., Suite 880, 
Evanston, IL 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
16
conditions
Endeavor Health Medical Group
1000 Central St., Suite 880, 
Evanston, IL 

Overview

Christopher Ray Trevino, MD, a neurologist at Endeavor Health, evaluates and treats conditions of the brain, spine and nervous system. Dr. Trevino provides care for neurologic concerns such as seizures, migraines and movement disorders using evidence-based diagnostic tools and therapies.

Dr. Trevino is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Metastatic Brain Tumor, Glioma, Brain Tumor, and Ependymoma.

Dr. Trevino is board certified in American Board Of Psychiatry And Neurology and United Council For Neurologic Subspecialties. He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 3 clinical trials. Dr. Trevino is currently accepting new patients.

Specialties

Neurology
Hematology
Oncology

Licenses

Psychiatry & Neurology in IL

Board Certifications

American Board Of Psychiatry And Neurology
United Council For Neurologic Subspecialties

Fellowships

University of Texas MD Anderson Cancer Center, Neuro-Oncology, 2019

Hospital Affiliations

Swedish Hospital
Northshore University Healthsystem - Evanston Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 17 Less Insurance Carriers -

Locations

Endeavor Health Medical Group
1000 Central St., Suite 880, Evanston, IL 60201
Other Locations
Endeavor Health Medical Group
2650 Ridge Ave., Kellogg Cancer Center, Evanston, IL 60201
Endeavor Health Medical Group
2180 Pfingsten Rd., Kellogg Cancer Center, Glenview, IL 60026

Additional Areas of Focus

Dr. Trevino has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
Enrollment Status: Completed
Publish Date: April 22, 2026
Intervention Type: Other, Biological, Procedure, Drug, Radiation, Device
Study Drugs: Ipilimumab, Nivolumab, Temozolomide
Study Phase: Phase 2/Phase 3
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
Enrollment Status: Active_not_recruiting
Publish Date: April 15, 2026
Intervention Type: Drug
Study Drugs: Berubicin, Lomustine
Study Phase: Phase 2
Genomically-Guided Treatment Trial in Brain Metastases
Genomically-Guided Treatment Trial in Brain Metastases
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Paxalisib, Entrectinib
Study Phase: Phase 2
View 2 Less Clinical Trials

6 Total Publications

Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.
Journal: medRxiv : the preprint server for health sciences
Published: July 03, 2026
Similar Doctors
Expertise in
38
conditions
Dr. Rimas V. Lukas
Hematology Oncology | Neurology | Hematology
Expertise in
38
conditions
Dr. Rimas V. Lukas
Hematology Oncology | Neurology | Hematology
Referral may be required
Before you request
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
 (12.2 miles away)
312-695-4360
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rimas Lukas is a Hematologist Oncology specialist and a Neurologist practicing medicine in Chicago, Illinois. Dr. Lukas is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioma, Glioblastoma, Brain Tumor, and Gastrostomy. Dr. Lukas is board certified in American Board Of Psychiatry And Neurology - Neurology (Certified). Dr. Lukas is currently accepting new patients.

Expertise in
16
conditions
Dr. Roger Stupp
Hematology Oncology | Neurology | Hematology
Expertise in
16
conditions
Dr. Roger Stupp
Hematology Oncology | Neurology | Hematology
Referral may be required
Before you request
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
 (12.2 miles away)
312-695-4360
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Roger Stupp is a Hematologist Oncology specialist and a Neurologist practicing medicine in Chicago, Illinois. Dr. Stupp is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Stupp is currently accepting new patients.

Expertise in
26
conditions
Dr. Priya U. Kumthekar
Hematology Oncology | Neurology | Hematology
Expertise in
26
conditions
Dr. Priya U. Kumthekar
Hematology Oncology | Neurology | Hematology
Referral may be required
Before you request
675 N St Clair St Ste 20-100, Galter Pavilion, 
Chicago, IL 
 (12.2 miles away)
312-695-4360
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Priya Kumthekar is a Hematologist Oncology specialist and a Neurologist practicing medicine in Chicago, Illinois. Dr. Kumthekar is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Brain Tumor. Dr. Kumthekar is board certified in American Board Of Psychiatry And Neurology - Neurology (Certified). Dr. Kumthekar is currently accepting new patients.

Frequently Asked Questions about Dr. Christopher R. Trevino

How do I make an appointment with Dr. Christopher R. Trevino?

You can book an appointment with Dr. Christopher R. Trevino by calling their office at 847-570-2570. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Christopher R. Trevino a top-rated expert for Metastatic Brain Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christopher R. Trevino is classified as an Advanced expert for Metastatic Brain Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Christopher R. Trevino specialize in?

While Dr. Christopher R. Trevino is a Neurology, they have specific expertise in Metastatic Brain Tumor, Glioma, and Brain Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Christopher R. Trevino participate in research or clinical trials?

Yes. Dr. Christopher R. Trevino has published 6 articles and abstracts on conditions like Metastatic Brain Tumor. You can view a list of Dr. Christopher R. Trevino's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Christopher R. Trevino accept my insurance?

Dr. Christopher R. Trevino accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 847-570-2570 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Trevino's expertise for a condition
ConditionClose
      View All 16 Advanced Conditions
      View All 41 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile